Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCQ | Q04759 | 20/20 | 0.79 |
| ▸ | PRKCD | Q05655 | 20/20 | 0.79 |
| ▸ | LYN | P07948 | 1/20 | 0.60 |
| ▸ | PRKCH | P24723 | 1/20 | 0.60 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2928488 | 1.00 | PRKCQ (0.79) | PRKCQPRKCDLYNPRKCHPRKCE | |
| SCHEMBL2932635 | 0.89 | PRKCQ (1.00) | PRKCQPRKCDLYNPRKCHPRKCE | |
| SCHEMBL2932633 | 0.89 | PRKCQ (1.00) | PRKCQPRKCDLYNPRKCHPRKCE | |
| SCHEMBL2931819 | 0.87 | PRKCQ (0.78) | PRKCQPRKCDLYNPRKCHPRKCE | |
| SCHEMBL2933491 | 0.87 | PRKCQ (0.78) | PRKCQPRKCDLYNPRKCHPRKCE | |
| SCHEMBL2935962 | 0.87 | PRKCQ (1.00) | PRKCQPRKCDLYNPRKCHPRKCE | |
| SCHEMBL2930057 | 0.87 | PRKCQ (1.00) | PRKCQPRKCDLYNPRKCHPRKCE | |
| SCHEMBL2931663 | 0.86 | PRKCQ (1.00) | PRKCQPRKCDLYNPRKCHPRKCE | |
| SCHEMBL2926971 | 0.86 | PRKCQ (0.79) | PRKCQPRKCDLYNPRKCHPRKCE | |
| SCHEMBL2926976 | 0.86 | PRKCQ (0.79) | PRKCQPRKCDLYNPRKCHPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2229377-A1 | 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS | Wyeth LLC (US) | 2010-09-22 | — | — | EP | disclosed |
| WO-2009076602-A1 | 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS | WYETH (US) | 2009-06-18 | — | — | WO | disclosed |